Pandemic Package

Package Medications

1. Ivermectin 6mg Tablets (Qty: 30)

Drug Class:
Antiparasitic agent (Avermectin derivative)

Labeled Uses:

• Treatment of certain parasitic infections:

  • Strongyloidiasis of the intestinal tract

  • Onchocerciasis (river blindness)

  • Some other nematode (roundworm) infections and ectoparasitic infestations (e.g., head lice, scabies)

Common Unlabeled (Off-Label) Uses:

• Treatment of scabies (especially crusted/scabies resistant to topical therapy)

• Lice infestations (when topical treatment is impractical)

• Some interest (controversially) for COVID-19 treatment/prevention (not FDA-approved; not recommended by CDC/WHO due to lack of proven efficacy and safety)

Dosage Recommendations:

• Strongyloidiasis: 200 mcg/kg orally once; may repeat after 2 weeks if necessary.

• Onchocerciasis: 150 mcg/kg orally once, may repeat every 6–12 months.

• Scabies/Lice (off-label): 200 mcg/kg orally as a single dose, repeated after 7–14 days.

Note:
6mg tablet: Dosage is weight-based; typical adult dose = 12mg (for 60kg), but always calculate per weight.

2. Hydroxychloroquine 200mg Tablets (Qty: 60)

Drug Class:
Antimalarial and disease-modifying antirheumatic drug (DMARD)

Labeled Uses:

• Malaria prophylaxis and treatment

• Rheumatoid arthritis (RA)

• Systemic lupus erythematosus (SLE)

• Discoid lupus erythematosus

Common Unlabeled (Off-Label) Uses:

• Chronic Q fever

• Porphyria cutanea tarda

• COVID-19 (research only; not recommended due to lack of efficacy and safety concerns)

• Some other autoimmune and dermatologic conditions

Dosage Recommendations:

• RA/SLE: 200–400 mg daily (usually divided in 1–2 doses; do not exceed 400 mg/day long term).

• Malaria prophylaxis: 400 mg once weekly starting 2 weeks before exposure and continuing 4 weeks after leaving endemic area.

• Acute malaria: 800 mg initially, then 400 mg at 6, 24, and 48 hours.

Note:
Dose adjustments for renal/hepatic impairment; regular eye exams recommended for long-term use due to risk of retinopathy.

3. Doxycycline 100mg Tablets (Qty: 100)

Drug Class:
Tetracycline-class antibiotic

Labeled Uses:

• Infections caused by susceptible bacteria, including:

  • Respiratory tract infections

  • Acne

  • Chlamydia and other STIs

  • Rickettsial infections (e.g., Rocky Mountain spotted fever)

  • Lyme disease

  • Malaria prophylaxis

Common Unlabeled (Off-Label) Uses:

• Community-acquired MRSA infections (skin/soft tissue)

• Q fever, Brucellosis, and more

• COVID-19 (not recommended except as part of research or secondary bacterial infection)

Dosage Recommendations:

• General infections: 100 mg orally every 12 hours (twice daily)

• Acne: 50–100 mg orally once or twice daily

• Malaria prophylaxis: 100 mg daily, starting 1–2 days before travel, through 4 weeks after leaving endemic area

Note:
Take with a full glass of water and remain upright for at least 30 minutes to minimize esophageal irritation. Avoid dairy/antacids close to dosing.

4. Prednisone 20mg Tablets (Qty: 50)

Drug Class:
Systemic corticosteroid (glucocorticoid)

Labeled Uses:

• Treatment of a wide variety of inflammatory and autoimmune conditions:

  • Allergic reactions

  • Asthma, COPD exacerbations

  • Rheumatoid arthritis, lupus, other autoimmune diseases

  • Certain cancers

  • Adrenal insufficiency (as replacement therapy)

  • Many other inflammatory/immune-mediated conditions

Common Unlabeled (Off-Label) Uses:

• Bell’s palsy

• Severe COVID-19 (when dexamethasone is unavailable)

• Other acute and chronic inflammatory conditions

Dosage Recommendations:

• Typical range: 5–60 mg daily, depending on condition and severity.

• Acute asthma/COPD: 40–60 mg daily for 5–10 days.

• Autoimmune: Often start high, then taper as symptoms improve.

Note:
Duration and dose depend heavily on indication. Tapering is required for long-term use to avoid adrenal insufficiency.

5. Vitamin D 60,000 IU Capsules (Qty: 12, Weekly Dose)

Drug Class:
Fat-soluble vitamin (nutritional supplement, hormone analog)

Labeled Uses:

• Prevention and treatment of vitamin D deficiency

• Management of osteoporosis (as adjunct)

• Hypoparathyroidism

• Rickets and osteomalacia

Common Unlabeled (Off-Label) Uses:

• Immune modulation (potential benefit in autoimmune diseases; ongoing research)

• Mood regulation, muscle function, cardiovascular health (supplemental use)

Dosage Recommendations:

• Vitamin D deficiency: 50,000–60,000 IU orally once weekly for 6–8 weeks, then maintenance (usually 800–2000 IU/day).

• Maintenance: After correction, a lower maintenance dose is recommended.

• Toxicity risk increases at high doses—monitor blood levels if using for extended periods.

Note:
The weekly 60,000 IU dose is a high-dose regimen used for deficiency correction, not for long-term maintenance.